2m 2m 2m 2m 2m 2m 2m
COGNITION THERAP (CGTX)
NASDAQ
$0.71-$0.04 (-4.77%)
Price as of Oct 22, 2026 7:54 PM EDT- $71.0MMarket Cap
- -56.08%1-Year Change
- BiotechnologyIndustry
COGNITION THERAP (CGTX)
$0.71-$0.04 (-4.77%)
CGTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.75 | ||
Change | +$0.01 (+1.74%) | ||
Open | $0.74 | ||
High | $0.76 | ||
Low | $0.74 | ||
Previous Close | $0.73 | ||
Volume | 297,045 | ||
30-Day Average Volume | 585,735 | ||
1-Week Change | -3.88% | ||
1-Month Change | -25.34% | ||
1-Year Change | -56.08% | ||
3-Year Change | -42.12% | ||
5-Year Change | -93.86% | ||
Fundamentals | |||
Shares Outstanding | 95.1M | ||
Total Assets | $38.9M | ||
Market Cap | $71.0M | ||
Enterprise Value | $37.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$3.9M | ||
Free Cash Flow | -$3.1M | ||
EBIT | -$3.9M | ||
EBITDA | -$3.9M | ||
Net Working Capital | $32.8M | ||
EPS | -$0.04 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -19 | ||
PEG | -1 | ||
Price/Free Cash Flow | -23 | ||
Price/Operating Cash Flow | -23 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue